Ionis Pharmaceuticals (IONS) Shares Outstanding (Weighted Average) (2016 - 2025)
Historic Shares Outstanding (Weighted Average) for Ionis Pharmaceuticals (IONS) over the last 16 years, with Q3 2025 value amounting to $159.8 million.
- Ionis Pharmaceuticals' Shares Outstanding (Weighted Average) rose 751.85% to $159.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.8 million, marking a year-over-year increase of 751.85%. This contributed to the annual value of $149.5 million for FY2024, which is 441.65% up from last year.
- Latest data reveals that Ionis Pharmaceuticals reported Shares Outstanding (Weighted Average) of $159.8 million as of Q3 2025, which was up 751.85% from $159.1 million recorded in Q2 2025.
- In the past 5 years, Ionis Pharmaceuticals' Shares Outstanding (Weighted Average) registered a high of $159.8 million during Q3 2025, and its lowest value of $140.8 million during Q1 2021.
- In the last 5 years, Ionis Pharmaceuticals' Shares Outstanding (Weighted Average) had a median value of $143.1 million in 2023 and averaged $145.8 million.
- As far as peak fluctuations go, Ionis Pharmaceuticals' Shares Outstanding (Weighted Average) skyrocketed by 57.46% in 2022, and later surged by 906.77% in 2025.
- Quarter analysis of 5 years shows Ionis Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $141.0 million in 2021, then rose by 0.59% to $141.8 million in 2022, then grew by 0.95% to $143.2 million in 2023, then grew by 4.42% to $149.5 million in 2024, then rose by 6.86% to $159.8 million in 2025.
- Its last three reported values are $159.8 million in Q3 2025, $159.1 million for Q2 2025, and $158.7 million during Q1 2025.